Stojkovic M, Machado SA, Stojkovic P, Zakhartchenko V, Hutzler P, Goncalves PB, Wolf E
GLP-1 receptor agonists, such as semaglutide (sold under the brand name Ozempic or Wegovy) and tirzepatide (brand name Mounjaro or Zepbound), are medications originally developed for diabetes and now approved for chronic weight management at specific doses
Weight regain following the cessation of medication for weight management: a systematic review and meta-analysis
Well help you uncover whats holding you back and design a plan that actually works for your body
Tirzepatide early phase trials showed lower eligibility (39.5%, 35.4%, 31.3%) with high variability (SD 28.929.6%), reflecting the diversity of early phase study designs
After eight reuse cycles, 20 g L-carnitine g -1 cells were produced in 30 h